Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in <i>BRCA1/BRCA2</i> Mutation Carriers Versus Non-Carriers.

Cancers (Basel) · 2019 · PMC6627684 · PMID 31141992

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Discussion Our initial analysis revealed slightly worsened DFS and DSS in BRCA1/BRCA2 mutation carriers compared with non-carriers; however, the difference was less than 10% at 10 years and marginally significant for DSS only (HR = 1.65 95% CI 1.01–2.70).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.